On the other side, COX-2 can be targeted by non-steroidal anti-inflammatory drugs (NSAIDs) and its inhibition, alone or in combination with other therapies, can reduce tumor growth and metastasis in experimental and canine comparative models for human breast cancer, as well as in vitro studies (32, 37–44). The gene discussed is PTGS2; the disease is breast cancer.